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VP5, a 5-terminal, small open reading frame in segment A of the aquatic birnavirus (infectious pancreatic necrosis virus,
IPNV) genome, encodes a 17-kDa nonstructural protein. We previously reported apoptosis induced by IPNV in a fish cell line.
In the present study, we cloned and identified VP5 and tested its function. Comparisons of the amino acid sequence of VP5
with well-known Bcl-2 family member proteins showed that the VP5 protein contains Bcl-2 homology (BH) domains BH1, BH2,
BH3, and BH4 but without the transmembrane region. VP5-stable clones enhanced viability, prevented membrane blebbing,
delayed DNA internucleosomal cleavage, and decreased virus titer during IPNV infection but, when deleted, BH domains 1
and 2 could lose the preventable ability. In addition, VP5 was demonstrated to be able to enhance or assist in maintaining
the functional half-life of survival factor Mcl-1 and regulate specific viral protein expression during the early replication cycle.
Finally, we found that VP5 was capable of enhancing cell viability when cells were exposed to UV irradiation. In summary,
these results suggest that the aquatic birnavirus may utilize a notable strategy via VP5 to regulate the host apoptosis-offINTRODUCTION
Apoptosis plays a protective role systemically by elim-
inating cells that might prove harmful if allowed to sur-
vive. For example, those cells harboring mutations fol-
lowing irradiation or chemical insult and which could
lead to cancer are eliminated by apoptotic processes.
Further, some cells may even be eliminated in order to
protect against virus infection (O’Brien, 1998). Thus, un-
derstanding the biochemical and molecular events that
control apoptosis may ultimately lead to a novel means
of dealing with disease.
Bcl-2, a proto-oncogene originally identified as an
overexpressed membrane protein in follicular lympho-
mas carrying a t(14;18) chromosomal translocation
(Cleary et al., 1986), has been shown to delay or even
block apoptosis induced by numerous, often unrelated
physiological and pathological stimuli (Reed, 1994).
Bcl-2, through its hydrophobic C-terminus, is anchored to
the outer membranes of mitochondria (Kroemer et al.,
1997; Thomson, 2001), the endoplasmic reticulum (ER),
and the nucleus (Krajewski et al., 1993), where it may
form a cation-selective ion channel (Minn et al., 1997),
block the release of cytochrome c from mitochondria into
the cytosol (Kroemer, 1997; Thomson, 2001), and attract
cytosolic adapter molecules (Reed, 1997). The multiple
functions of Bcl-2 probably serve to prevent the activa-217tion of the ced-3/caspase-3 subfamily in response to
apoptotic stimuli and thus suppress the death effector
machinery (Boulakia et al., 1996; Monney et al., 1996). To
date, more than a dozen cellular and viral Bcl-2 homo-
logues have been identified (Reed, 1997; Kelekar and
Thompson, 1998). There are many examples of viruses
that kill cells apoptotically; in most cases, apoptosis is a
defense mechanism beneficial for the host cell because
it curtails the infection cycle and prevents neighboring
cells from being infected with progeny virions (Vaux et
al., 1994). At one extreme, the host defense system is
circumvented by the presence of anti-apoptotic proteins,
such as bcl-2 (Levine et al., 1993), that either exist in host
cells or are brought into the cells by viruses, such as viral
latent membrane protein-1 (LMP-1) of Epstein–Barr virus
and E1-B of adenovirus (Hendersen et al., 1991; Rao et
al., 1992). Subsequent to viral infection, host cells typi-
cally survive and persistently produce progeny virions
(viral persistence). At the other extreme, viruses may
provoke pathological lesions because they benefit from
the anti-apoptotic properties of the host cells for repro-
duction but then kill these cells by overcoming their
survival potential at a later stage (Ubol et al., 1994;
O’Brien, 1998).
Infectious pancreatic necrosis virus (IPNV) is a fish
pathogen and is the prototype of the Birnaviridae virus
family (Dobos et al., 1979). Birnaviruses possess a bi-
segmented (A and B), double-stranded RNA genomesystem for enhancing progeny production. © 2002 Elsevier S
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duction of four unrelated major genes that undergo var-
ious posttranslational cleavage processes in order to
generate three to five structural proteins (Dobos, 1995).
The largest protein, VP1, is encoded by the smaller seg-
ment B genomic RNA, and the larger genome segment A
encodes VP2, VP4, and VP3 proteins. Genome segment
A contains an additional small, open reading frame (ORF)
that overlaps the amino-terminal end of the polyprotein
from the reading frame (Duncan et al., 1987). This small
ORF encodes a 17-kDa arginine-rich minor polypeptide,
VP5, which is produced in small quantities and is syn-
thesized during the early replication cycle (Magyar and
Dobos, 1994). Our particular interest is in unveiling the
molecular mechanisms that govern the survival and
death of cells infected by IPNV. We previously reported
that apoptosis may be induced by IPNV infection in a fish
cell line (Hong et al., 1998, 1999a) and subsequently
found that viral proteins contribute to the down-regula-
tion of survival factor Mcl-1 during IPNV-induced apopto-
tic cell death (Hong et al., 1999b). In the present study,
we cloned and characterized the nonstructural viral pro-
tein VP5, which may either regulate specific viral protein
expression or delay apoptotic cell death in the early
replication cycle of IPNV infection. To the best of our
knowledge, this is the first study to demonstrate that a
novel viral Bcl-2 family member can arise from a double-
stranded RNA virus, IPNV having been shown to prevent
down-regulation of host Mcl-1 to enhance cell survival.
This finding might provide an important insight into a
Bcl-2 family member, VP5, that uses a novel strategy
against host defense response in a virus’ early replica-
tion cycle from a double-stranded RNA virus.
RESULTS
The early expression of VP5 protein in IPNV-infected
CHSE-214 cells
This small ORF encodes a 17-kDa arginine-rich minor
polypeptide, VP5, which is produced in small quantities
and is synthesized during the early cell replication cycle
(Magyar and Dobos, 1994). In our system, the pattern of
VP5 in uninfected and IPNV-infected CHSE-214 cells was
labeled by a continuous-labeling process using [35S]me-
thionine. The data indicated that the major proteins
pVP2, VP3, and VP4 were readily distinguished in in-
fected cells (data not shown) as early as 3 h subsequent
to infection, and no polypeptides of comparable sizes
became labeled in uninfected cells. On the other hand,
the nonstructural protein VP5 in IPNV-infected CHSE-214
cells was labeled (Fig. 1, lanes 8–14) such that it was
readily distinguishable in infected cells as early as 3 h
subsequent to infection, the degree of expression in-
creasing rapidly at around 6 h postinfection (p.i.); the VP5
was finally completely degraded at 24 h p.i. (Fig. 1, lane
13).
Cloning of VP5
We used two specific primers to clone the nonstruc-
tural protein VP5 using a one-step RT-PCR process from
total RNA extracted from cells at 6 h p.i. The alignment of
the nucleotide sequence of VP5 and the deduced amino
acid sequence are indicated in Fig. 2, the cDNA of VP5
being 444 bp in length. The molecular weight of VP5 is
FIG. 1. Identification of VP5 expression pattern in CHSE-214 cells.
Both the uninfected and IPNV-infected cells were labeled with [35S]me-
thionine at different times and analyzed using a 12% SDS–PAGE assay.
For the uninfected group, lanes 1–7 correspond to labeled polypeptide
released by virus-infected cells lysed after 3, 4, 6, 8, 10, 24, and 36 h,
respectively. For the infected group, lanes 7–12 correspond to labeled
polypeptide released by virus-infected cells lysed after 3, 4, 6, 8, 10, 24,
and 36 h, respectively.
FIG. 2. Alignment of nucleotide sequence and deduced amino acid
sequence of IPNV E1-S VP5. The primary structure of VP5 in the IPNV
E1-S strain and its localization of Bcl-homology domains are shown by
underlining. The arginine-rich residues are shown in shaded blocks.
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about 17 kDa and the interval contains a 16-arginine
residue as shown by the underlined section in Fig. 2.
Bcl-2-related proteins that share homology in one to
four regions, designated Bcl-2 homology (BH) domains
BH1, BH2, BH3, and BH4, are depicted in Fig. 3A. VP5
contains the conserved BH1, BH2, BH3, and BH4 do-
mains, which are indicated in boxes (Fig. 3A). According
to the domain organization, the anti-apoptotic members
of the Bcl-2 family proteins are classified into class I and
class II (10). We found that VP5 belongs to a new class of
anti-apoptotic Bcl-2 members, because its domain orga-
nization [i.e., lacking a transmembrane region (TM) but
including the BH1 to BH4 domains] may allow it to be
classified into class III (Fig. 3B).
Enhancing viability and reducing the virus titer of VP5
during IPNV E1S infection
The stable transfectants containing the CHSE-Neo
were of two types, those without the VP5 gene (desig-
nated the negative control) and those with the VP5 gene
present, these being designated CHSE-VP5-1 and CHSE-
VP5-2. The VP5 gene was identified from stable trans-
fectants by a one-step RT-PCR process. As indicated in
Fig. 4A, a high level of VP5 expression occurred (lanes
3–4) as compared to CHSE-Neo cells (lane 2). Following
this, we then tested the prevention of the cell death
function in the overexpression of the VP5 cell line. Fig-
ures 4B–4G depict the phase-contrast micrographs of
cell viability for cells experiencing and those not experi-
encing IPNV infection [multiplicity of infection (m.o.i.) 
1] at 24 h p.i. The viability of VP5 transfectants and Neo
transfectant cells was measured at serial time points
subsequent to IPNV infection using a trypan blue exclu-
sion technique (Fig. 4H). For the m.o.i. 1 infection group,
at various time points including 0, 4, 8, 12, and 24 h, in the
control group (CHSE-Neo cell) the majority of cells were
viable from 100, 110, 63, 45, and 10%, respectively. By
contrast, in the group containing VP5 the viability of the
majority of CHSE-VP5-1 cells was enhanced 100, 133,
120, 115, and 38%, respectively, and in the CHSE-VP5-2
FIG. 3. Alignment of amino acid residues in the Bcl-homology domain (BH1–4) of Bcl-2-related proteins. (A) Alignment of amino acids is from the
conserved BH1, BH2, BH3, and BH4 domains of VP5 and other Bcl-2 family members. The conserved amino acids for residues common to at least
five of the family members are shown in shaded blocks. (B) Classification of the Bcl-2 family proteins from anti-apoptotic protein members based upon
domain organization. The general architecture of the anti-apoptotic members of the proteins is shown (not to scale); BH domains and TM domains
are labeled. The VP5 protein does not exhibit the TM domain of Bcl-2.
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100, 103, 118, 70, and 15%, respectively. Figure 4H dem-
onstrates that both the CHSE-VP5-1 and the CHSE-VP5-2
cell lines revealed greater cell viability than the CHSE-
Neo cell line, when assessed at 12 h p.i. On the other
hand, for the m.o.i. 10 infection group, the containing-VP5
group also consistently showed that VP5 could enhance
the cell viability from 46% (CHSE-Neo) to 80% (CHSE-
VP5-1) and 68% (CHSE-VP5-2) at 12 h p.i. (Fig. 4I). At 24 h
p.i., for the m.o.i. 1 group, their cell supernatants’ titers
were estimated according to the TCID50 (Table 1). We
found that the presence of VP5 could decrease the
TCID50 from a value of 7.0 to 6.0 (for CHSE-VP5-1) and
6.25 (for CHSE-VP5-2).
Prevention of morphological changes in virus-infected
cells
Apoptosis is characterized morphologically by cell
shrinkage and the presence of hyperchromatic nuclear
fragments and biochemically by chromatin cleavage into
nucleosomal oligomers (Wyllie et al., 1980). We com-
pared the CHSE-Neo and CHSE-VP5-1 cells with a m.o.i.
value of unity at 12 h p.i. Figure 5A shows that almost
50% of the cells are blocked from the early apoptotic
stage (cell round-up) to the middle stage (membrane
blebbing) and finally enter the late stage to form the ap-
optotic body. These sequential morphological changes
having been previously described (Hong et al., 1999a). By
contrast, the viability of the CHSE-VP5-1 cells appeared
to be 10% below the value for the cell rounding-up stage
and about 2–3% for the entrance to the middle apoptotic
stage (Fig. 5B).
Delayed induction of internucleosomal cleavage in
CHSE-VP5 cells
DNA fragmentation is a well-defined biochemical
marker of apoptosis (Wyllie et al., 1980). We therefore
examined the ability of VP5 to delay the induction of
DNA fragmentation in a fish embryonic cell line. In-
tense internucleosomal fragmentation of DNA was ob-
served in IPNV-infected CHSE-Neo cells at a 8 h p.i.,
but not among IPNV-infected CHSE-VP5-1 cells at up
to 12 h p.i. (Fig. 5C).
TABLE 1
Effect of VP5 Expression on Virus Progeny Infectivitya
Time (p.i.)
TCID50
b
CHSE-Neo CHSE-VP5-1 CHSE-VP5-2
24 h 7.0 6.0 6.25
a Results are representative of three independent experiments.
b Determined at 24 h p.i. with IPNV E1-S (m.o.i.  1).
FIG. 4—Continued
FIG. 4. Expression of VP5 delayed the cell death of CHSE-VP5-1 and CHSE-VP5-2 stable clones during IPNV infection. (A) Characterization of VP5
gene expression from a VP5 stable cell line. The VP5 from a stable transfectant was amplified by one-step RT-PCR (see Materials and Methods). Lane
1 is a 1-kb ladder marker (BRL); lanes 2–4 are from CHSE-Neo, CHSE-VP5-1, and CHSE-VP5-2, respectively. (B–D) Phase-contrast images of uninfected
CHSE-Neo, CHSE-VP5-1, and CHSE-VP5-2 cells, respectively, at 24 h p.i., as a negative control; (E–G) phase-contrast images of IPNV-infected
CHSE-Neo, CHSE-VP5-1, and CHSE-VP5-2, respectively, at 24 h p.i. Bar, 20 m. (H) Viability of CHSE-Neo (open squares), CHSE-VP5-1 (open
diamonds), and CHSE-VP5-2 (open circles) clones expressing VP5 subsequent to IPNV infection (m.o.i.  1). (I) Viability of CHSE-Neo (open squares),
CHSE-VP5-1 (open diamonds), and CHSE-VP5-2 (open circles) clones expressing VP5 following IPNV infection (m.o.i.  10). Cell viability at each time
point for each cell line was determined in triplicate; each point represents the mean cell viability of three independent experiments  SEM.
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VP5 could regulate the viral protein expression and
maintain the half-life of Mcl-1 levels
From the data revealed in Fig. 1, it would appear that
the polypeptide VP5 is an early expression protein, and
from the results presented in Figs. 4 and 5 it appears that
overexpression of VP5 could enhance the cell viability
and delay the DNA internucleosomal cleavage at a late
virus-replication cycle. It thus is of interest to be able to
determine whether VP5 could regulate other viral pro-
teins or, in fact, even host survival factor expression. The
expression patterns of the major capsid protein VP2 and
the submajor capsid protein VP3 in CHSE-VP5-1 and
CHSE-Neo clones that were examined using Western
blot analysis at serial time points subsequent to IPNV
infection are indicated in Fig. 6A. The precursor expres-
sion of major capsid protein VP2 (pVP2-1) and submajor
protein VP3 in CHSE-VP5-1 and CHSE-Neo cells was
traced by personal densitometer (Molecular Dynamics).
We found that the pVP2-1 expression in CHSE-VP5-1
could be limited by at least 30% in the whole replication
cycle (as shown in Fig. 6D) compared with CHSE-Neo
cells at 6, 12, and 24 h p.i. In contrast, we observed the
very conflict-expression pattern of VP3 in CHSE-VP5
cells compared with pVP2-1 protein (Fig. 6E). Briefly,
FIG. 5. Prevention of morphological changes and blocked DNA fragmentation by VP5. (A, B) Phase-contrast images illustrating the morphological
changes of apoptosis induced in CHSE-VP5 cell lines by IPNV infection. (A) IPNV-infected CHSE-Neo cells may induce different morphological
changes for different apoptotic cell stages from the early stage (short arrows), middle stage (medium arrows), and late stage (long arrows) 12 h p.i.
(B) IPNV-infected CHSE-VP5-1 cells may block the morphological changes of apoptotic cells, showing the small number of cells entering the early
stage (short arrows) and middle stage (medium arrows), but not the late stage, 12 h p.i. Bar, 1 m. (C) DNA fragmentation analysis of CHSE-Neo and
CHSE-VP5-1 cells infected with IPNV E1-S (m.o.i. of 1). DNA was isolated (as described under Materials and Methods) for uninfected CHSE-Neo cells
and CHSE-VP5-1 cells as a negative control at 0 h p.i. (lanes 2 and 7) and 12 h p.i. (lanes 3 and 8); from infected CHSE-Neo cells with IPNV E1-s for
6, 8, and 12 h postinfection (lanes 4–6); and from infected CHSE-VP5-1 for 6, 8, and 12 h with m.o.i.  1 of IPNV E1-S (lanes 9–11). DNA was
electrophoresed through 1.2% agarose gels and visualized by ethidium bromide staining. Lane 1 contains the molecular weight markers used in the
gel (1-kb DNA ladder from BRL for sizing linear fragments ranging from 100 bp to 12 kb).
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during the overexpression of VP5 a resultant delay to the
major peak of VP3 protein expression could be observed
at about 6 h postinfection. The details are as follows: at
6 h p.i., the VP3 protein level in CHSE-VP5-1 cells ap-
pears to decrease by 52% compared with CHSE-Neo
cells. At 12 h p.i., VP3 in CHSE-VP5-1 cells appears to be
rapidly increasing the expression dose by about 18%
compared with CHSE-Neo cells. Finally, for CHSE-VP5-1
and CHSE-Neo cells there appears to be a virtually
equivalent level of VP3 expression at 24 h p.i. As regards
the survival factor Mcl-1 expression profile (as shown in
Figs. 6B and 6F), in total, we found that VP5 could
maintain the Mcl-1 expression level, possibly by enhanc-
ing its protein half-life. Specifically, VP5 could maintain
the Mcl-1 expression level at 6, 12, and 24 h at 127, 70,
and 82.5% compared with 0 h, respectively. But without
overexpression of the VP5 group (CHSE-Neo cell) the
MCL-1 is quickly down-regulated so that its expression
level dropped to 42.5, 12.5, and 8% compared with 0 h at
6, 12, and 24 h p.i., respectively. These data appear to be
consistent with the results indicated in Fig. 4, thus sug-
gesting that VP5 could maintain the MCL-1 expression
FIG. 6. Western blot assay of CHSE-VP5-1 cells on viral protein expression and host Mcl protein level changes after IPNV infection. (A) Expression
of viral protein patterns in CHSE-Neo and CHSE-VP5-1 cells following infection with IPNV E1-S (m.o.i.  1) for 0, 6, 12 and 24 h. Viral major VP2 and
submajor VP3 proteins were detected by Western blot analyses with polyclonal antibodies against E1-S virus particles. (B) Up-regulating expression
of host Mcl-1 protein levels in CHSE-VP5-1 cells during infection with IPNV (m.o.i.  1). Endogenous Mcl-1 was detected by Western blot analyses
with polyclonal antibodies against human Mcl-1 (PharMingen) from stripped panel A nitrocellulose membrane. (C) Internal control of actin in A and
B. Endogenous actin was detected by Western blot analyses with monoclonal antibodies against mouse (Amersham) from panel B stripped
nitrocellulose membrane. (D) Precursor VP2 (pVP2-1) or submajor capsid protein VP3 (E) and host Mcl-1 protein level (F) expression amounts were
quantified by Personal Densitometer (Molecular Dynamic) from pVP2-1 (52 kDa) and VP3 (32 kDa) of Fig. 4A and Mcl-1 (36.2 kDa) of Fig. 4B. The
percentages indicate the different levels of expression in CHSE-Neo cells and CHSE-VP5-1 cells during IPNV infection.
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level necessary to enhance the host cell viability during
IPNV infection.
Decreasing cell viability of VP5dBH1 and VP5dBH2
during IPNV E1S infection
When deleted, the BH1 and BH2 domains may be able
to influence the prevention of the cell death function. In
this regard, Fig. 7A demonstrates a deletion of a VP5
construction map. In an anti-apoptotic death functional
assay, the CHSE-Neo, CHSE-VP5-1, CHSE-VP5dBH1-2,
and CHSE-VP5dBH2 cell lines were used. From the re-
sults presented in Fig. 7B it would appear that the anti-
apoptotic function may be maintained from VP5 or de-
leted VP5 transfectants at 6 h p.i., although at 12 h p.i.,
the anti-apoptotic death function is apparently lost from
CHSE-VP5dBH1-2 cells (41.6%) and CHSE-VP5dBH2 cells
(41%) compared to CHSE-Neo cells (40%, as a negative
control) and cells containing the VP5 gene (CHSE-VP5-1
cells, 80%).
Enhancing cell viability of VP5 with UV irradiation
Here, we tested the anti-apoptotic death function of
VP5 using a classical stimulus such as UV irradiation.
The stable transfectants containing CHSE-Neo and
CHSE-VP5-1 were used for this investigation. The phase-
contrast micrographs of cell viability with UV irradiation
for 0.5 and 3 Gy at 16 h p.i. are shown in Fig. 8A. The
viability of VP5 transfectants and Neo transfectant cells
was measured subsequent to such UV irradiation using
a trypan blue exclusion method (Fig. 8B). We found that
VP5 was capable of enhancing the cell viability (95%)
when compared with Neo vector cells (70%) subsequent
to UV irradiation of 0.5 Gy. At the higher UV irradiation
level (3 Gy), the CHSE-VP5-1 cells were able to maintain
a high viability level (70%) compared to CHSE-Neo cells
(40%). Such consistent results from both the lower and
the higher UV-irradiation groups suggest that VP5 could
enhance cell viability from apoptosis.
DISCUSSION
The present study shows that a novel Bcl-2 family
member, VP5, can regulate the cellular survival factor
Mcl-1 and viral proteins through apoptosis in a fish cell
line. Analysis of the structural features of the VP5 protein
revealed that VP5 contains putative domains BH4, BH3,
BH1, and BH2 from the N-terminal to the C-terminal
FIG. 7. Loss of anti-apoptotic death function during deleted BH1 and BH2 domains from VP5. (A) The Bcl-homology domains of VP5 and its deleted
BH1 and BH2 domain mutants. The scale is not according to precise nucleotide size. (B) Viability of CHSE-Neo (open squares), CHSE-VP5-1 (open
diamonds), CHSE-VP5dBH1-2 (open circles), and CHSE-VP5dBH2 (open triangles) clones expressing no VP5, deleted VP5, and VP5 after IPNV
infection (m.o.i.  1). Cell viability for each time point for each cell line was determined in triplicate; each point represents the mean cell viability of
three independent experiments  SEM.
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region (Fig. 1), which would appear to be characteristic
of Bcl-2 family members.
A number of Bcl-2-related proteins have been previ-
ously identified (Kelekar and Thompson, 1998). While
some reveal anti-apoptotic activity similar to that of Bcl-2,
such as Bcl-xL (Boise et al., 1993), Mcl-1 (Kozopas et al.,
1997), and A1 (Lin et al., 1993), others appear to promote
apoptosis, such as Bax (Oltvai et al., 1993), Bak (Chit-
FIG. 8. Expression of VP5 prevented the cell death of CHSE-VP5-1 stable clone with UV irradiation. (A, a–d) The phase-contrast images of uninfected
CHSE-Neo or CHSE-VP5-1 with 0.5 Gy UV irradiation (a, b) or with 3 Gy UV irradiation (c, d) after 16 h of incubation. Bar, 10 m. (B) Viability of
CHSE-Neo (a) and CHSE-VP5-1 (b) with 0.5 Gy of UV irradiation and CHSE-Neo (c) and CHSE-VP5-1 (d) with 3 Gy of UV irradiation after 16 h of
incubation. Cell viability at each time point for each cell line was determined in triplicate; each point represents the mean cell viability of three
independent experiments  SEM.
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tenden et al., 1995), and Bad (Yang et al., 1995). Most
proteins in the Bcl-2 superfamily also harbor C-terminal
signal-anchor sequences that target these proteins pre-
dominantly on the outer mitochondrial membrane, endo-
plasmic reticular membrane, and outer nuclear envelope
(Krajewski et al., 1993; Boya et al., 2001; Thomson, 2001).
This new class member, VP5, however, appears to be
absent in the transmembrane domain in the C-terminal
region of the VP5 protein. It could thus belong to a new
class of Bcl-2 family members, termed class III; such an
anti-apoptotic member has been previously described
(Kelekar and Thompson, 1998).
According to its amino acid sequence, VP5 is a novel
Bcl-2 family member, hence it appears appropriate to
determine the role that the VP5 protein plays in the host
cell. Overexpression of VP5 in CHSE-214 cells enhanced
host viability during IPNV infection (Fig. 3) and delayed
the induction of internucleosomal cleavage by IPNV (Fig.
4). On the other hand, we observed consistent results
regarding the influence of the deletion of the BH2 domain
alone or the deletion of both the BH2 and BH1 domains,
in causing VP5 to lose its cell viability-enhancing func-
tion at 6 h p.i. (as shown in Fig. 6). Thus it appears that
the BH1 and BH2 domains are crucial for maintaining the
survival function of the death suppressor VP5. The BH1
and BH2 domains are found in all death antagonists of
the Bcl-2 family (Kelekar and Thompson, 1998). Residues
in the BH1 and BH2 domains are essential for the sur-
vival function of the death suppressors Bcl-2 and Bcl-xL
and for interactions with death agonists such as Bax
(Oltavai et al., 1993) and Bak (Chittenden et al., 1995).
Furthermore, VP5 is absent in the C-terminal signal-
anchor sequence (TM), unlike other Bcl-2 family mem-
bers that predominantly target the outer mitochondrial
membrane, endoplasmic reticular membrane, and outer
nuclear envelope (Krajewski et al., 1993). We propose
that VP5 might act through a different mechanism in-
volved in regulating cell death by IPNV infection, al-
though further experiments are required to clarify the
interaction of other proteins with viral protein in the lower
vertebrate (fish) system.
Many viruses have evolved genes encoding proteins
that effectively suppress or delay apoptosis and conse-
quently still maintain host survival for the production of
sufficient quantities of progeny. For example, the adeno-
viral E1B gene (19-kDa protein) (Boyed et al., 1994), the
BHRF1 gene of EBV (Henderson et al., 1993), and the
LMW5-HL gene of ASFV (Chacon et al., 1995) encode
homologues of cellular Bcl-2, an inhibitor of apoptosis.
To the best of our knowledge, to date, no member of the
viral Bcl-2 family has yet been reported from any double-
stranded RNA virus or fish virus. The IPN virus replica-
tion process is localized in the cytoplasm and one rep-
lication cycle takes about 16–20 h at 22°C, resulting in a
characteristic cytopathic effect (CPE) (Monney et al.,
1996). In our system, we found that viral protein synthesis
or virus replication is associated with the down-regula-
tion of the expression of the survival factor Mcl-1, which
induces host cells to undergo apoptotic cell death at a
relatively low m.o.i. We propose that viral protein expres-
sion between 6 and 8 h subsequent to IPNV infection
may be involved in either the direct or the indirect down-
regulation of the Mcl-1 pathway (Hong et al., 1999b). Our
data show (Figs. 4 to 6) that VP5 can also delay the
induction of DNA internucleosomal cleavage to rescue
or prevent cells from undergoing apoptotic cell death
either by maintaining the Mcl-1 protein level or by limit-
ing specific viral protein expression during IPNV infec-
tion. VP5 is the early expression gene as shown in Fig. 1
(Magyar and Dobos, 1994). We found that VP5 may play
a novel function that both blocks the host defense sys-
tem from triggering apoptosis (Tschopp et al., 1998; Roul-
ston et al., 1999) and regulates viral-death gene expres-
sion in an early replication stage, thus enhancing the
virus production. On the other hand, we examined the
anti-apoptotic role that VP5 plays following UV irradia-
tion, the results of which appear to be consistent with
those presented in Fig. 4 that demonstrate the general
anti-death function that VP5 displays. Recently, we re-
ported that the death effector Bad gene could be in-
duced, its expression occurring during the early replica-
tion cycle (Hong and Wu, 2002), and that other effectors
such as caspase(s) (Boulakia et al., 1996; Monney et al.,
1996) may be activated in order to drive the apoptotic
death pathway. Finally, however, how VP5 induces the
down-regulation of Mcl-1 and disrupts VP5 function for
inducing postapoptotic necrosis at the pre-late apoptotic
stage (Hong et al., 1998) warrants further investigation.
MATERIALS AND METHODS
Cells and viruses
Chinook salmon embryo cells (CHSE-214) were ob-
tained from the American Type Culture Collection
(ATCC). CHSE-214 cells were grown at 18°C in plastic
tissue-culture flasks (Nunc) using Eagle’s minimum es-
sential medium (MEM) supplemented with 10% (v/v) fetal
calf serum and 25 g/ml of gentamicin.
The isolated virus, E1-S, a member of the Ab strain of
IPNV, was obtained from Japanese eels in Taiwan (Wu et
al., 1987) and was propagated in CHSE-214 monolayer
cells at a m.o.i. of 0.01 per cell. Virus-infected cultures
were incubated at 18°C until an extensive CPE was
observed (Dobos, 1977). Virus plaque assays (Dobos,
1977) and TCID50 were performed on confluent monolay-
ers of CHSE-214 cells (Nicholson and Dunn, 1974).
Radioactive labeling and analysis of viral protein from
IPNV-infected cells
Confluent CHSE-214 monolayer cells in plastic tissue
culture plates (60 mm in diameter, Nunc) were infected
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with IPNV (for the virus-infected group) at 18°C at a m.o.i.
of 10, the cells being allowed 1 h for adsorption. Follow-
ing this, the medium was removed from the virus-in-
fected group and the normal control group culture plates,
the monolayers were rinsed three times with phosphate-
buffered saline (PBS), and the uncovered plate was irra-
diated with UV light as previously described by Wu et al.
(1998). Methionine-free medium (Gibco) that contained
actinomycin D (1 g/ml) was used for the virus-infected
group and the normal control group, and starvation pro-
ceeded for 2 h at 18°C. At 2 h postinfection, growth
medium was added containing 50 Ci/ml of [35S]methi-
onine. Subsequent to the completion of the labeling
period, and at various time intervals thereafter, including
1, 2, 4, 6, 8, and 22 h, respectively, the cell layer was
washed with PBS, and the monolayer was lysed in 0.4 ml
of electrophoresis sample buffer and then heated for 2
min in a boiling water bath. Radioactively labeled pro-
teins were analyzed in the slab gels, using a discontin-
uous SDS-gel system as previously described by Lae-
mmli (1970). The 12% separating gel and 5% stacking gel
were prepared with an acrylamide to bisacrylamide ratio
of 30:0.8. Fifty to 60 l of labeled cell lysate placed into
a total volume of 400 l (and exhibiting a 20,000- to
40,000-cpm intensity) was loaded into wells. Electro-
phoresis continued for 14 to 16 h at 60 V. The slab gel
was dried under vacuum, autoradiographed, and then
exposed to undeveloped film.
Cloning of VP5
VP5 was amplified by one-step RT-PCR from total RNA
derived from cells 6 h p.i. (Chirgwin, 1979) with VP5
mRNA as a template. Two oligonucleotide primers were
used including VP5p1 (5ATGGCGAAG CCCTTTCTAAC-
3) and VP5p2 (5-ACAGACTTCCTTCGAAGGTG-3). The
VP5 mRNA was reverse-transcribed in 50 l of reaction
mixture containing 1 g of total RNA, 20 ng each of the
oligonucleotide primers, the dNTPs at a final concentra-
tion of 10 M each, 2 units each of Superscript II reverse
transcriptase and Taq DNA polymerase (RT/Taq mixture),
and 25 l of reaction buffer at 42°C for 30 min. The
first-strand cDNA of VP5 was followed by pre-denatur-
ation at 94°C for 2 min. The second-strand cDNA of VP5
was amplified using a 35-cycle PCR process, with each
cycle consisting of a denaturation step of 15 s at 94°C,
an annealing step of 30 s at 42°C, an extension step at
72°C for 1 min/kb, and one cycle of a final extension at
72°C for 10 min. The PCR products were fractionated
using gel electrophoresis, and DNA fragments of the
expected size (0.45 kb) were extracted from the gel by
an oligonucleotide purification kit and cloned into
pcDNA3.1/V5/His-Eukaryotic TOPO TA cloning vector
(Shuman, 1994). The resulting clones were sequenced
using a single base reaction and using the ABI Prism 377
DNA sequencer according to the manufacturer’s proto-
col. Complete sequence analysis was then performed on
a representative clone. The VP5 gene accession number
is AF160258.
VP5 and VP5 BH domain-deleted transfectants
VP5-producing cells were obtained by transfecting
CHSE-214 cells with a TOPO vector containing the VP5
gene and by selecting with G418 for 10–12 weeks (Hong
et al., 1999a). The VP5 BH1 and BH2 domain-deleted
constructs were used as the specific primers to amplify
the VP5dBH1-2 (249 nt) and VP5dBH2 (373 nt) by PCR
and to then ligate the inserts to the TOPO vector. The
plasmids were transfected with Lipofectamine Plus
(Gibco BRL) to CHSE-214 cells and selected with 800
g/ml G418 for 10–12 weeks.
Quantification of cell viability
To test whether VP5 functions in an anti-apoptotic
capacity during IPNV infection, the transfectants that we
used contained the CHSE-Neo and two VP5 stable cell
lines. The CHSE-Neo, CHSE-VP5-1, and CHSE-VP5-2 cell
lines were seeded in plastic tissue plates (60 mm in
diameter, Nunc) and were either infected with m.o.i. 1 of
IPNV E1-S for 0, 4, 8, 12, and 24 h or with m.o.i. 10 for 12
and 24 h at 18°C. At the end of the various culture
periods, both virus-infected CHSE-Neo cells and virus-
infected VP5 stable cells were examined by light micros-
copy using phase-contrast optics (Nikon), following
which the cells were washed with PBS and the mono-
layers treated with 0.5 ml of 0.1% trypsin–EDTA (Gibco)
for 1 to 2 min. Cell viability was determined using a
trypan blue dye-exclusion assay (Alnemri and Litwack,
1990), the results of which were expressed as means 
SEM. Data were analyzed using either a paired or un-
paired Student’s t test as appropriate. A value of P 
0.05 was taken to represent a statistically significant
difference between mean values of groups.
DNA preparation and gel electrophoresis
Approximately 105 of CHSE-Neo and CHSE-VP5-1 cells
per milliliter were seeded on a 60-mm petri dish and
allowed to remain in culture conditions for more than
20 h. The CHSE-Neo and CHSE-VP5-1 cell monolayers
were treated with virus at m.o.i. 1 and were incubated for
various time periods including 0, 6, 8, and 12 h. Unin-
fected control cells were also incubated for 0 and 12 h. At
the completion of incubation, cells were lysed with lysis
buffer (10 mM Tris–HCl, 0.25% Triton X-100, 1 mM EDTA,
pH 7.4). After treatment with phenol:chloroform:isoamyl
alcohol (25:24:1), genomic DNA was precipitated in the
presence of 0.3 M sodium acetate and cold absolute
ethanol at 70°C for 2 h and then resuspended in 10
mM Tris–HCl (pH 7.4) and 1 mM EDTA. Aliquots of 20 l
containing approximately 5 to 10 g of genomic DNA
were then electrophoresed in 1.2% agarose gels for 2 h at
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40 V. Gels were stained with ethidium bromide and
photographed under UV transillumination.
Immunoblotting
Approximately 105 of CHSE-Neo and CHSE-VP5-1 cells
per milliliter were seeded on a 60-mm petri dish and
allowed to remain in culture for more than 20 h. The cell
monolayers were rinsed twice with PBS, infected with
m.o.i. 1 of IPNV, and incubated for various time periods
including 0, 6, 12, and 24 h. Uninfected control cells were
also incubated for the same periods of time. At the
completion of each incubation period, the culture me-
dium was aspirated, and cells were washed with PBS
and then lysed in 0.3 ml lysis buffer (Kelekar and Thomp-
son, 1998) (10 mM Tris-base, 20% glycerol, 10 mM SDS,
2% -ME, pH 6.8).
Proteins were separated by SDS–polyacrylamide gel
electrophoresis (Laemmli, 1970), electroblotted, and sub-
jected to immunodetection as described (Kain et al.,
1994). Blots were incubated with a 1:1500 dilution of
immunoglobulin fraction (Clontech) and a 1:7500 dilution
of peroxidase-labeled goat anti-rabbit conjugate (Amer-
sham). Chemiluminescence detection was performed
according to the instructions provided with the Western
Exposure Chemiluminescent Detection System (Amer-
sham). Chemiluminescent signals were imaged by expo-
sure to Kodak XAR-5 film (Eastman Kodak, Rochester,
NY). Stripping of the primary and secondary antibodies
from blots was achieved by incubation in stripping buffer
containing 62.5 mM Tris–HCl (pH 6.8), 3.0% (wt/vol) SDS,
and 50 mM 1,4-dithiothreotol for 30 min at 55°C with
gentle shaking. The blots were washed three times in
PBS containing 0.1% (vol/vol) Tween 20 for 10 min each
and reprobed with antibodies beginning at the mem-
brane blocking step (Kain et al., 1994).
Prevention of cell death from CHSE-VP5 cell by UV
irradiation
To assay the cell viability of the CHSE-Neo and CHSE-
VP5-1 cells subsequent to their having been UV-irradi-
ated, confluent control cells including CHSE-Neo and the
CHSE-VP5-1 stable cell line in plastic tissue plates (60
mm in diameter, Nunc) were exposed to 0.5–3.0 Gy of UV
irradiation (for time intervals of between 30 s and 3 min)
and subsequently incubated for 16 h at 18°C. At the end
of the culture periods, the cells of both CHSE-Neo and
CHSE-VP5-1 stable cells were examined by light micros-
copy using phase-contrast optics (Nikon). Following this,
the cells were washed with PBS and the monolayers
were treated with 0.5 ml of 0.1% trypsin–EDTA (Gibco) for
between 1 and 2 min. Cell viability was determined using
a trypan blue dye exclusion assay (Alnemri and Litwack,
1990). Results were expressed as means  SEM. Data
were analyzed using either a paired or an unpaired
Student’s t test as appropriate. A value of P  0.05 was
taken to represent a statistically significant difference
between mean values of groups.
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